Surgical Resection for Residual N2 Disease After Induction Chemotherapy

This publication has 15 references indexed in Scilit:

• Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer
  European Journal Of Cancer, 2003
• Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA‐bulky N2 and Stage IIIB nonsmall cell lung carcinoma
  Cancer, 2003
• A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209)
  The Journal of Thoracic and Cardiovascular Surgery, 2003
• Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non-Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2002
• Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial
  Lung Cancer, 1999
• Result of induction chemotherapy followed by surgery in patients with stage IIIA N2 NSCLC: importance of pre-treatment mediastinoscopy
  European Journal of Cardio-Thoracic Surgery, 1999
• Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
  Lung Cancer, 1998
• Results of cancer and leukemia group B protocol 8935
  The Journal of Thoracic and Cardiovascular Surgery, 1995
• A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1994
• Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients
  The Annals of Thoracic Surgery, 1993